MENS: Rata-rata rega prakiraan Jyong Biotech Corp

The price action of Jyong Biotech Ltd (MENS) relies on stable raw material logistics that eliminate supply disruptions, with the metric reaching 0.00. Jyong Biotech Ltd develops plant-based medicines through Asian alliances and acquires distribution networks. However, business success is constrained by strict regulatory oversight and the potential for failure during new product launches, which could dampen financial performance.

MENS (Jyong Biotech) riwayat Bagan rega target saka 18.06.2025 nganti 22.10.2026

Rincian analitis perusahaan Jyong Biotech Corp (MENS)

MENS — sistem indikator bursa lan keuangan Jyong Bio:

Kutipan saham jyongbio.com|MENS - Prakiraan konsensus analis|Nilai pasar Jyong Biotech Corp

Analisis umum perusahaan:MENS jyongbio.com

Barang unggulan Jyong Bio

The potential of Jyong Biotech Ltd (MENS) depends on successfully navigating regulatory hurdles when bringing plant-based pharmaceuticals to market. The consensus forecast aggregates average fair value estimates of the stock from leading investment houses, reflecting the collective expectations of analysts. This metric allows for a comparison between the current price and the asset's fundamental value. Investors utilize this indicator to determine the long-term capitalization trend. By analyzing the dynamics of the market's target consensus, one can assess the permissible risks of margin lending.

Pesaing Jyong Biotech Ltd

Target konsensus haleon.com HLN|Prakiraan konsensus analis KVUE (Kenvue)|Verona Pharma PLC (VRNA) - Rata-rata rega prakiraan|LGND - Bagan rega target|AMRX (Amneal Corp) - Prakiraan gabungan firma investasi|Perrigo Company plc (PRGO) - Bagan rega target|ALVO - Target median analis|Bagan rega target Liquidia|Galapagos N.V. - Bagan tingkat prakiraan|Prakiraan konsensus analis ANIP|MNKD (Afrezza) - Konsensus nilai wajar|Prakiraan konsensus analis AMPH (Amphastar Pharmaceuticals)|Prakiraan konsensus analis pacira.com PCRX|SPRY - Bagan rega target|Konsensus nilai wajar TBPH (Theravance Biopharma Inc)|Aquestive Pharma (AQST) - Bagan rega target|Target konsensus scPharmaceuticals|TECX (Tectonic Therapeutic Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis tonixpharma.com|Target konsensus SXTC (China SXT Pharmaceuticals)|EPRX (eupraxiapharma.com) - Konsensus nilai wajar|Bagan rega target BioHarvest BHST|Invizyne (EXOZ) - Rata-rata rega prakiraan|ORMP: Target konsensus|Entera Bio Ltd. - Rega prakiraan analis|HYFT: Prakiraan konsensus analis|ABVC BioPharma Inc. - Konsensus nilai wajar|CPIX (Cumberland Pharma) - Prakiraan konsensus analis|Rata-rata rega prakiraan Quantum BioPharma Corp QNTM|Bagan rega target FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Konsensus nilai wajar|Bagan rega target Rani Therapeutics Holdings, Inc. RANI|Rega prakiraan analis SNYR (Synergy CHC Corp.)|RLYB: Target konsensus|Rata-rata rega prakiraan Lexaria Bioscience|Pulmatrix, Inc. (PULM) - Bagan rega target|Rata-rata rega prakiraan Pheton Holdings (PTHL)|Bagan rega target Aptorum Group Ltd|Prakiraan gabungan firma investasi LYRA (Lyra Therapeutics Inc.)|Prakiraan konsensus analis IBO|tnfpharma.com (TNFA) - Rentang target analis|cbdMD - Target konsensus|Konsensus nilai wajar PRFX|Auris Medical - Prakiraan konsensus analis|LIPO: Bagan rega target|OPTN: Prakiraan konsensus analis|PIRS - Target median analis|Bagan rega target Procaps Group S.A.|Rata-rata rega prakiraan petrospharma.com PTPI|Target konsensus QLI (Qilian International Holding)|Rega prakiraan analis SLRN|Prakiraan konsensus analis TFFP (TFF Pharma)